11.24
Schlusskurs vom Vortag:
$8.93
Offen:
$10.9
24-Stunden-Volumen:
5.86M
Relative Volume:
1.17
Marktkapitalisierung:
$6.76M
Einnahmen:
$5.66M
Nettoeinkommen (Verlust:
$-15.88M
KGV:
-0.9935
EPS:
-11.3134
Netto-Cashflow:
$-10.93M
1W Leistung:
+18.87%
1M Leistung:
+2,173%
6M Leistung:
+993.40%
1J Leistung:
+55.78%
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Firmenname
Bioaffinity Technologies Inc
Sektor
Branche
Telefon
210-698-5334
Adresse
3300 NACOGDOCHES ROAD, SAN ANTONIO
Compare BIAF vs TMO, DHR, NTRA, IQV, IDXX
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
BIAF
Bioaffinity Technologies Inc
|
11.25 | 5.36M | 5.66M | -15.88M | -10.93M | -11.31 |
|
TMO
Thermo Fisher Scientific Inc
|
599.53 | 222.97B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
203.30 | 144.27B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
NTRA
Natera Inc
|
327.14 | 46.72B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
IQV
Iqvia Holdings Inc
|
256.08 | 42.67B | 16.63B | 1.39B | 2.12B | 8.0674 |
|
IDXX
Idexx Laboratories Inc
|
520.77 | 40.98B | 4.45B | 1.10B | 1.06B | 13.59 |
Bioaffinity Technologies Inc Aktie (BIAF) Neueste Nachrichten
bioAffinity Technologies regains Nasdaq compliance after bid-price recovery - TradingView
BIAF Stock Pops As CyPath Lung Wins Federal Distribution - StocksToTrade
Nasdaq cancels hearing after a biotech company regains compliance - Stock Titan
Top Small Cap Stocks To ConsiderSeptember 7th - MarketBeat
Trending Stocks Today | BioAffinity Technologies Shoots up 56.75% - Moomoo
Small Cap Stocks To Follow NowSeptember 5th - MarketBeat
BIAF Stock Slides As bioAffinity’s Dilution And Reverse Split Reshape Trading Setup - StocksToTrade
bioAffinity’s AI Lung-Cancer Stock Jumped Nearly 48% After a Reverse Split. What Would Have to Go Right? - Yahoo Finance
AOUT, NX, and BIAF stocks soar on strong earnin... - pluang.com
bioAffinity Technologies Inc. Warrant (BIAFW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
$15.5 to $19.35 🫡 - Moomoo
You know I'm drunk, so my words carry extra weight 😘 - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
bioAffinity Technologies to Present Corporate Update at Conference - TipRanks
bioAffinity Technologies to Present Corporate Update at H.C. Wainwright Conference; Market Cap ~$5.9M - TradingView
bioAffinity Technologies to Participate in the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance
bioAffinity Technologies and AvMEDICAL Announce Nationwide Federa - The National Law Review
Biotech Stocks To Follow NowSeptember 3rd - MarketBeat
BIAF Stock Pops As Federal Lung Test Deal Fuels Momentum - timothysykes.com
BIAF Stock Jumps As Federal Deal Fuels Lung Test Growth - StocksToTrade
bioAffinity Technologies Shares Rise After CyPath Lung Surveillance Update - Yahoo Finance
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
BIAF Stock Pops As CyPath Lung Scores Big VA Deal - timothysykes.com
Why is bioAffinity Technologies stock surging today? By Investing.com - Investing.com Nigeria
Small Cap Stocks To Watch NowSeptember 2nd - MarketBeat
bioAffinity Technologies Surges as CyPath Lung Expands Into Cancer Recurrence Monitoring - finance.biggo.com
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
BioAffinity Technologies Stock Skyrockets Wednesday: What's Happening? - Benzinga
bioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer Survivors - BioSpace
Get insights into the top gainers and losers of Tuesday's after-hours session. - ChartMill
bioAffinity Technologies advances CyPath Lung for post-treatment surveillance - TradingView
Why Is bioAffinity Technologies Stock Trading Higher Today?bioAffinity Technologies (NASDAQ:BIAF) - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Top Biotech Stocks Worth WatchingSeptember 1st - MarketBeat
bioAffinity Technologies Advances CyPath Lung for Post-Treatment Lung Cancer Surveillance - Yahoo Finance
BIAF jumps as bioAffinity highlights expanded CyPath Lung use case - Quiver Quantitative
bioAffinity shares jump 45% on CyPath news, trading volume rises to 56 times share count - TechStock²
BIAF Stock Surges On VA Deal And Lung Test Momentum - StocksToTrade
BIAF Stock Pops As Federal Deal Fuels Volatile Run - timothysykes.com
$bioAffinity Technologies (BIAF.US)$ sold a tad early.. but managed to kept my greens! - Moomoo
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
bioAffinity (BIAF) Results Review: The EPS Result Is Below Expectation for This Review; Closing Reaction: The Market Price Declines 1.25% at the CloseEstimate Revision Count - vinanet.vn
bioAffinity Technologies Inc. Warrant (BIAFW) Peer Comparison – Compare with Others - Value Research
Price to earnings forward of bioAffinity Technologies, Inc. – BOATS:BIAFW - TradingView
bioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026 - BioSpace
bioAffinity Technologies Implements Reverse Stock Split for Nasdaq - TipRanks
bioAffinity Technologies Sets 1-for-15 Reverse Stock Split for August 24 - citybiz
bioAffinity Technologies executes 1-for-15 reverse stock split - Investing.com
BioAffinity Technologies Announces 1-for-15 Reverse Stock Split Effective at the Open of Trading on August 24, 2026 - marketscreener.com
bioAffinity (BIAF) Earnings Snapshot: The Available Earnings Metric Delivers a Miss in the Reported Period; Trading Move: The Stock Ends Down 13.59% in Latest TradingFinancial Summary - vinanet.vn
Finanzdaten der Bioaffinity Technologies Inc-Aktie (BIAF)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):